10-Q: BIO-key International Q2 2026: Revenue Up, Losses Persist

BIO-key International reported increased revenues for Q2 2026 driven by license fees, but continued to incur significant operating losses and faces ongoing liquidity challenges.

Summary

• BIO-key International filed its Form 10-Q for the quarter ended June 30, 2026.
• Total revenues increased by 13% to $1.92 million for the three months ended June 30, 2026, compared to $1.70 million in the prior year period.
• License fee revenue saw a significant increase of 53% to $1.23 million.
• However, the company reported an operating loss of $529,405 for the quarter, an improvement from $1.08 million in the prior year, but still a substantial loss.
• Net loss for the quarter was $576,852, compared to $1.17 million in the prior year.
• Cash and cash equivalents decreased to $1.38 million as of June 30, 2026, from $2.69 million at the end of 2025.
• The company continues to operate with a going concern warning, citing insufficient cash for twelve months of operations and dependence on future financing.
• Subsequent events include a warrant exercise generating $2.5 million in gross proceeds and exchange agreements with a note lender.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the company's ongoing struggles with profitability, cash flow, and the going concern warning, despite some revenue growth in specific segments.

Positives

• Total revenues increased by 13% to $1.92 million for the three months ended June 30, 2026.
• License fee revenue increased significantly by 53% to $1.23 million for the three months ended June 30, 2026.
• Hardware sales increased by 23% to $990,898 for the six months ended June 30, 2026.
• Operating loss improved to $529,405 for the three months ended June 30, 2026, from $1.08 million in the prior year.
• Net loss improved to $576,852 for the three months ended June 30, 2026, from $1.17 million in the prior year.
• Disclosure controls and procedures were deemed effective by management.
• Trading of common stock recommenced on the Nasdaq Capital Market on July 8, 2026, after an appeal.

Negatives

• The company reported a net loss of $576,852 for the three months ended June 30, 2026.
• Cash and cash equivalents decreased to $1.38 million as of June 30, 2026, from $2.69 million at December 31, 2025.
• The company has a history of losses and negative cash flow from operations.
• There is substantial doubt about the company's ability to continue as a going concern within one year.
• The company requires approximately $750,000 per month for operations, which it has been unable to consistently achieve through revenue generation.
• The company has approximately $2.1 million of inventory purchased for projects in Nigeria that are delayed.
• The company's common stock was suspended from trading on the Nasdaq Capital Market on May 13, 2026, due to non-compliance with listing requirements.

Risks

• The company's history of losses, negative cash flow from operations, and dependence on obtaining additional financing raise substantial doubt about its ability to continue as a going concern.
• The company may be unable to generate sufficient revenue and positive cash flow from operations or liquidate existing inventory to fund current operations and execute its business plan.
• If available financing is insufficient or unavailable, or if the company fails to generate sufficient revenue, it may be required to further reduce operating expenses, delay expansion, be unable to pursue acquisitions, or cease operations.
• The company's common stock was suspended from trading on the Nasdaq Capital Market due to failure to regain compliance with minimum bid requirements and timely filing of reports.
• The company faces competition in the biometric technology and identity access management industries.
• The company's ability to protect its intellectual property is a risk.
• Changes in business conditions, sales strategy, product development plans, and market acceptance of biometric products pose risks.
• The company's ability to convert sales opportunities to customer contracts and expand into new markets is subject to risk.

Future Outlook

The company plans to continue offering a suite of authentication options to complement its biometric solutions and grow its business within government services and highly-regulated industries. Growth strategies include increased marketing, pursuit of large-scale identification projects, and expanding its channel alliance program. The company also plans to pursue strategic acquisitions in the IAM space.

Management Comments

• Management believes that biometrics should continue to play a key role in remote user authentication.
• Management expects that the compatible, yet superior portable biometric user experience offered by their technology for Windows 10 users will accelerate demand for their computer network log-on solutions and fingerprint readers.
• Management believes that continued heightened security and privacy requirements in government services and highly-regulated industries will generate increased demand for security solutions, including biometrics.

Industry Context

StockSavvy.ai notes that the identity and access management (IAM) market continues to expand, driven by increased remote work, cybersecurity threats, and regulatory requirements. BIO-key's focus on biometrics and multi-factor authentication aligns with these trends, but the company faces significant challenges in converting market opportunities into profitable growth.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry standards or benchmarks for key financial metrics.
• The company's operating loss and net loss indicate performance below industry profitability standards for established IAM providers.
• The going concern warning suggests a liquidity and financial stability position that is significantly weaker than typical industry players.

Legal Proceedings

• As of June 30, 2026, the company was not a party to any pending lawsuits.

Stakeholder Impact

• Shareholders may experience dilution if the company needs to raise additional capital through equity offerings.
• The going concern warning and stock trading suspension create uncertainty for investors regarding the company's future viability.
• Employees may face job security concerns due to the company's financial challenges and need for cost reductions.
• Customers may be concerned about the long-term availability of BIO-key's products and services given the company's financial situation.

Next Steps

• The company is working on initiatives to mitigate losses and improve cash flow, including selling delayed Nigerian inventory into other markets.
• The company will continue to explore other markets and opportunities to sell its products to generate additional cash.
• The company plans to continue offering a suite of authentication options and grow its business within government services and highly-regulated industries.
• The company will continue to pursue strategic acquisitions of select businesses and assets in the IAM space.
• The company intends to use net proceeds from warrant exercises for working capital and general corporate purposes, including repayment of outstanding secured notes.

Key Dates

Recommendation

The company's persistent net losses, negative cash flow, significant debt obligations, and the explicit going concern warning, despite some revenue growth, indicate a high level of financial risk. The recent stock trading suspension and ongoing need for external financing further underscore the precarious financial position, making it a speculative investment with a high probability of further downside.

Keywords

identity access management, biometric technology, PortalGuard, SaaS, cybersecurity, authentication, software solutions, enterprise security